Financial Tearsheet
Company Overview
ENDRA Life Sciences' mission is to bring new capabilities to ultrasound and broaden access to better healthcare.
ENDRA's Photo-Acoustic Nexus-128 system is currently used by leading global medical researchers to screen and modify disease models.
ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) system to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI -- at a fraction of the cost, and at the point-of-care.
ENDRA's first TAEUS application will focus on the quantification of fat in the liver, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease, which affects over 1 billion people globally.
Recent Financial News
IR Contacts
| MZ Group |
|
Chris Tyson
|
Stock Performance
| Today's Open | 2.24 |
| Volume | 168,396 |
| Day Range | 2.10 - 2.34 |
| 52 Week Range | 1.55 - 5.88 |
| Bid/Ask | 2.11 / 2.15 |
| Bid/Ask Size | 200 X 500 |
| Previous Close | 2.25 |
| Market Cap | 11.61 million |
| Shares Outstanding | 5.43 million |
| Dividend/Yield | 0.00 / 0.00% |
| EPS (TTM) | -2.477200 |
| P/E Ratio (TTM) | N/A |
